Improving Treatment of Giardiasis

Journal Title: Актуальна інфектологія - Year 2015, Vol 3, Issue 8

Abstract

Giardiasis is one of the most common parasitic diseases in both children and adults, and is revealed in all countries of the world. Despite the wide range of etiotropic drugs, there remains a need to improve the treatment. The objective of therapy is not only the eradication of the pathogen, but also the elimination of the consequences of its presence in the body. When choosing etiotropic drug for the treatment of giardiasis there has been considered not only the antiparasitic efficacy of Macmiror (nifuratel), but also the safety and good tolerability. The spectrum of antibacterial activity of nifuratel: — protozoa: Lamblia intestinalis, Trichomonas vaginalis, Entamoeba histolytica; — pathogenic fungi: Candida albicans, Microsporum spp., Trichophyton spp.; — bacteria: – Gram-negative: E.coli, Shigella spp., Salmonella spp., Proteus spp., Klebsiella spp., Vibrio cholerae; – Gram-positive: Staphylococcus spp., Streptococcus spp., Helicobacter pylori. The ability of Macmiror to be eliminated by the kidneys almost completely, without involvement of the liver detoxification reserves, is equally important. An examination of the state of eubiosis in children receiving Macmiror has shown a positive effect of the drug on the intestinal microflora. Based on the individual results of the study and review of the literature data, it was found that Macmiror is one of the most effective and safe drug in the treatment of giardiasis.

Authors and Affiliations

I. B. Yershova, H. O. Moсhalova, T. F. Osypova, O. V. Petrenko

Keywords

Related Articles

Interrelation of Immunological and Clinic-Morphological Parameters in Patients with Chronic Hepatitis C Depending on Mixed Cryoglobulinemia

Introduction. Mixed cryoglobulinemia is the most common extrahepatic manifestations of chronic HCV-infection. Questions about the role of cytokines and features of liver injury in patients with chronic HCV-infection with...

Improving Treatment of Giardiasis

Giardiasis is one of the most common parasitic diseases in both children and adults, and is revealed in all countries of the world. Despite the wide range of etiotropic drugs, there remains a need to improve the treatmen...

Carbapenems in clinical practice

Increasing frequency of infections caused by multi-drug resistant organisms is currently observed in the adult and pediatric population. It is the clinician’s responsibility to use wide-spectrum antibiotics when appropri...

Echinococcosis in children (clinical case of pulmonary echinococcosis in 8-year-old girl)

The article presents the results of a review on echinococcosis in children and a clinical case of pulmonary echinococcosis in 8-year-old girl. In recent years, the number of patients with echinococcosis has increased not...

Download PDF file
  • EP ID EP214326
  • DOI -
  • Views 90
  • Downloads 0

How To Cite

I. B. Yershova, H. O. Moсhalova, T. F. Osypova, O. V. Petrenko (2015). Improving Treatment of Giardiasis. Актуальна інфектологія, 3(8), 49-54. https://europub.co.uk./articles/-A-214326